TAUNS Laboratories, Inc.
197A.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥2 | ¥1 | ¥6 | ¥6 |
| % Growth | 132.2% | -81.9% | 1.2% | – |
| Cost of Goods Sold | ¥1 | ¥1 | ¥2 | ¥2 |
| Gross Profit | ¥2 | ¥0 | ¥4 | ¥4 |
| % Margin | 68.8% | 8.8% | 70.5% | 70.3% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥1 | ¥1 | ¥1 | ¥1 |
| Sales & Mktg Exp. | ¥0 | ¥1 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| Operating Expenses | ¥1 | ¥1 | ¥1 | ¥1 |
| Operating Income | ¥1 | -¥1 | ¥3 | ¥3 |
| % Margin | 23.1% | -104.5% | 49.6% | 50.2% |
| Other Income/Exp. Net | -¥0 | -¥0 | -¥0 | -¥0 |
| Pre-Tax Income | ¥1 | -¥1 | ¥3 | ¥3 |
| Tax Expense | ¥0 | -¥1 | ¥1 | ¥1 |
| Net Income | ¥0 | -¥0 | ¥2 | ¥2 |
| % Margin | 15.1% | -32.4% | 34.8% | 35.8% |
| EPS | 3.47 | -3.23 | 19.14 | 19.57 |
| % Growth | 207.4% | -116.9% | -2.2% | – |
| EPS Diluted | 3.33 | -3.05 | 17.94 | 18.55 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥0 | ¥0 | ¥0 | ¥0 |
| EBITDA | ¥1 | -¥1 | ¥3 | ¥3 |
| % Margin | 31.2% | -85.8% | 53.1% | 53.4% |